dr. Julie Deckers

Journal Article
A1
open access

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base

Sieglinde De Cae (UGent) , Inge Van Molle, Loes van Schie (UGent) , Sophie R. Shoemaker, Julie Deckers (UGent) , Nincy Debeuf (UGent) , Sahine Lameire (UGent) , Wim Nerinckx (UGent) , Kenny Roose (UGent) , Daria Fijalkowska (UGent) , et al.

(2025) NATURE COMMUNICATIONS. 16(1).

Add to list

Journal Article
A1
open access

Amplification of protein expression by self-amplifying mRNA delivered in lipid nanoparticles containing a β-aminoester ionizable lipid correlates with reduced innate immune activation

Emily De Lombaerde, Xiaole Cui (UGent) , Yong Chen (UGent) , Zifu Zhong (UGent) , Julie Deckers (UGent) , Giulia Mencarelli, Lisa Opsomer (UGent) , Haixiu Wang, Jamie De Baere (UGent) , Stefan Lienenklaus, et al.

(2024) ACS NANO. 18(41). p.28311-28324

Add to list

Journal Article
A2
open access

TCR transgenic clone selection guided by immune receptor analysis and single-cell RNA expression of polyclonal responders

Nincy Debeuf (UGent) , Sahine Lameire (UGent) , Manon Vanheerswynghels (UGent) , Julie Deckers (UGent) , Caroline De Wolf (UGent) , Wendy Toussaint (UGent) , Rein Verbeke (UGent) , Kevin Verstaen (UGent) , Hamida Hammad (UGent) , Stijn Vanhee (UGent) , et al.

(2024) ELIFE. 13.

Add to list

Journal Article
A1
open access

Inhaled GM-CSF administered during ongoing pneumovirus infection alters myeloid and CD8 T cell immunity without affecting disease outcome

Nincy Debeuf (UGent) , Julie Deckers (UGent) , Sahine Lameire (UGent) , Cedric Bosteels (UGent) , Hamida Hammad (UGent) and Bart Lambrecht (UGent)

(2024) FRONTIERS IN IMMUNOLOGY. 15.

Add to list

Miscellaneous
open access

TCR transgenic clone selection guided by immune receptor analysis and single cell RNA expression of polyclonal responders

Nincy Debeuf (UGent) , Sahine Lameire (UGent) , Manon Vanheerswynghels (UGent) , Julie Deckers (UGent) , Caroline De Wolf (UGent) , Wendy Toussaint (UGent) , Rein Verbeke (UGent) , Kevin Verstaen (UGent) , Hamida Hammad (UGent) , Stijn Vanhee (UGent) , et al.

(2024) BIORXIV.

Add to list

Journal Article
A1
open access

Combinatorial screening of biscarbamate ionizable lipids identifies a low reactogenicity lipid for lipid nanoparticle mRNA delivery

Emily De Lombaerde, Yong Chen (UGent) , Tingting Ye, Julie Deckers (UGent) , Giulia Mencarelli, Kim Deswarte (UGent) , Heleen Lauwers (UGent) , Ruben De Coen (UGent) , Sabah Kasmi (UGent) , Sanne Bevers, et al.

(2024) ADVANCED FUNCTIONAL MATERIALS. 34(21). p.1-16

Add to list

Journal Article
A1
open access

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Karel Van Damme (UGent) , Levi Hoste (UGent) , Jozefien Declercq (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes, Liesbet Martens (UGent) , Roos Colman (UGent) , Robin Browaeys (UGent) , Cedric Bosteels (UGent) , Stijn Verwaerde (UGent) , et al.

(2023) SCIENCE TRANSLATIONAL MEDICINE. 15(710).

Add to list

Miscellaneous
open access

A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Karel Van Damme (UGent) , Levi Hoste (UGent) , Jozefien Declercq (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes, Liesbet Martens (UGent) , Roos Colman (UGent) , Robin Browaeys (UGent) , Cedric Bosteels (UGent) , Stijn Verwaerde (UGent) , et al.

(2023) medRxiv.

Add to list

Journal Article
A1
open access

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

Cedric Bosteels (UGent) , Karel Van Damme (UGent) , Elisabeth De Leeuw (UGent) , Jozefien Declercq (UGent) , Bastiaan Maes, Victor Bosteels, Levi Hoste (UGent) , Leslie Naesens (UGent) , Nincy Debeuf (UGent) , Julie Deckers (UGent) , et al.

(2022) CELL REPORTS MEDICINE. 3(12).

Add to list

Journal Article
A1
open access

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial

Elisabeth De Leeuw (UGent) , Karel Van Damme (UGent) , Jozefien Declercq (UGent) , Cedric Bosteels (UGent) , Bastiaan Maes, Simon Tavernier (UGent) , Laurent Detalle, Trevor Smart, Sophie Glatt, Nincy Debeuf (UGent) , et al.

(2022) RESPIRATORY RESEARCH. 23(1).

Academic Bibliography

dr. Julie Deckers

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base

Amplification of protein expression by self-amplifying mRNA delivered in lipid nanoparticles containing a β-aminoester ionizable lipid correlates with reduced innate immune activation

TCR transgenic clone selection guided by immune receptor analysis and single-cell RNA expression of polyclonal responders

Inhaled GM-CSF administered during ongoing pneumovirus infection alters myeloid and CD8 T cell immunity without affecting disease outcome

TCR transgenic clone selection guided by immune receptor analysis and single cell RNA expression of polyclonal responders

Combinatorial screening of biscarbamate ionizable lipids identifies a low reactogenicity lipid for lipid nanoparticle mRNA delivery

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19

A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial

Contents

Support

Contact